Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SIGACHI

SIGACHI

HealthcarePharmaceuticals & Biotechnology₹1080 cr market cap
₹27.56 ▼ -2.65% today As of 19 Nov 2026
52-week low ₹16.9252-week high ₹38.19

-25.9% from the 52-week high · +67.3% above the low

Sigachi Industries Ltd. engages in the manufacture and sale of microcrystalline cellulose. The company is headquartered in Hyderabad, Telangana. The company went IPO on 2021-11-15. The firm is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Company’s products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The firm's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. The company produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The firm offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. The company operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The firm serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.

The short version. SIGACHI reported revenue of ₹130 crore for Sep 2026, up 18.2% from a year earlier. Net profit was ₹10 crore (down 9.1% year on year). Return on equity was -15.7% in Mar 2026. Promoter holding was 36.69% in Sep 2026, down 8.02 points over 8 quarters.

1 · The price

How has the stock traded?

SIGACHI trades 25.9% below its 52-week high and 67.3% above its 52-week low.

Change over period: —

1M+6.0%
3M-2.0%
6M+38.6%
1Y-19.5%

2 · The business

Is it growing?

Sales, year on year+18.2%

Sep 2026 revenue of ₹130 cr.

Profit, year on year-9.1%

Sep 2026 net profit of ₹10 cr.

Net margin7.8%

1.9 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue130121122117110128128139
Net profit1078011-1001321
Net margin %7.85.66.30.29.7-78.310.315.3
EPS (₹)0.270.180.20.010.28-2.630.350.64

Annual

FY2026FY2025FY2024FY2023FY2022
Revenue478488399302250
Net profit-8270574440
Net margin %-17.114.214.314.416.0
EPS (₹)-2.141.821.741.421.3

3 · The quality

How well does it turn capital into profit?

Return on equity was -15.7% in Mar 2026; debt to equity is 0.26.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %-15.711.613.316.2
Return on capital %-12.915.815.319.7
EBITDA margin %-11.623.721.521.2
Net margin %-16.813.713.914.1

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR16.3%—
Profit CAGR——
Debt to equity0.26
Interest cover-5.3x
Current ratio1.44
P/E ratio43.3

4 · The owners

Who holds it, and are they adding?

Promoter holding36.69%

Down 8.02 pts over 8 quarters.

Foreign institutions0.52%

Up 0.36 pts over 8 quarters.

Domestic institutions0.05%

Up 0.05 pts over 8 quarters.

Mutual fund schemes2

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter44.7144.1444.1440.4839.736.6936.6936.69-8.02
FII0.160.082.893.13.331.31.250.52+0.36
DII00000000.05+0.05
Public55.1255.7852.9756.4156.9762.0162.0562.74+7.62

Mutual fund holdings · Oct 2026

2 schemes hold this stock

2 the month before.

  • Motilal Oswal BSE Healthcare ETF0.04% of NAV
  • Bandhan BSE Healthcare Index Fund0.04% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SIGACHI are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SIGACHI

What is the SIGACHI share price?

SIGACHI (SIGACHI) last closed at ₹27.56, down 2.65% on the day. Its 52-week range is ₹16.92 to ₹38.19.

What is the market cap of SIGACHI?

SIGACHI has a market capitalisation of about ₹1,080 crore. Its price-to-earnings ratio is 43.3.

How are SIGACHI's latest results?

SIGACHI reported revenue of ₹130 crore for Sep 2026, up 18.2% from a year earlier. Net profit was ₹10 crore (down 9.1% year on year). Return on equity was -15.7% in Mar 2026. Promoter holding was 36.69% in Sep 2026, down 8.02 points over 8 quarters.

Who owns SIGACHI?

As of Sep 2026, shareholding was: Promoter 36.69%, FII 0.52%, DII 0.05%, Public 62.74%.

How many mutual funds hold SIGACHI?

2 mutual fund schemes held SIGACHI in October 2026. That compares with 2 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 16 Sep 2025 · Final Dividend - Rs. 0.1
  • 28 Aug 2024 · Final Dividend - Rs. 0.1
  • 09 Oct 2023 · Stock Split From Rs.10/- to Rs.1/-
  • 31 Aug 2023 · Final Dividend - Rs. 1
  • 02 Aug 2022 · Interim Dividend - Rs. 1

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.